In a similar manner, CBLL1 gene expression was associated with non-mutant BRAF samples when analysing 205 samples of CRC patients (20 tumour samples with BRAF mutations and 195 tumour samples with non-mutated BRAF). This evidence concerns the gene CBLL1 and neoplasm.